Body Composition and Survival in Locally Advanced Rectal Cancer Patients Treated with Neoadjuvant Radiochemotherapy
Nutrients · 21.10.2025 · 17 (20) · 3309
DOI: 10.3390/nu17203309 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, online erschienen am 21.10.2025. Verfasst von Piotr Kolenda und 6 weiteren Autor:innen. Beteiligte Einrichtung: Greater Poland Cancer Centre, Department of Oncology and Immuno-Oncology, Garbary Str. 15, 61-866 Poznan, Poland. Hauptthemen laut MEDLINE: Rectal Neoplasms, Neoadjuvant Therapy, Body Composition, Chemoradiotherapy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Nutritional status is a recognized determinant of treatment tolerance and clinical outcomes in oncology. This study aimed to assess body composition using computed tomography (CT) and to evaluate its association with progression-free survival (PFS) and overall survival (OS) in patients with locally advanced rectal cancer (LARC) undergoing curative multimodal therapy.
Methods
A total of 216 patients with LARC who underwent neoadjuvant chemoradiotherapy (CRT) were retrospectively assessed. Two radiochemotherapy protocols were used: long-course chemoradiotherapy (lcCRT) (radiation therapy administered daily at doses of 1.8 or 2.0 Gy, for a total dose of 50.4–55.8 Gy) with concurrent chemotherapy: either 5-FU with leucovorin or capecitabine and total neoadjuvant chemoradiotherapy (tnCRT)—short-course radiotherapy (5 × 5 Gy) followed by sequential chemotherapy with CAPOX or FOLFOX. Surgery was performed 6.5 weeks after completing CRT. Radiotherapy was delivered using linear accelerators based on the Intensity-Modulated Radiation Therapy technique. CT scans were used to assess nutritional status. Survival analyses were performed. Data on food consumption frequency were collected using the Dietary Habits and Nutrition Beliefs Questionnaire (KomPAN®). Non-Healthy-Diet-Index-14 (nHDI-14) was calculated.
Results
Median observation time was 58 months (range 4–118 months). VATI level and OS (HR: 0.4618 95% CI: 0.2194–0.9719, p = 0.0419), as well as SATI and OS (HR: 0.4707 95% CI: 0.2286–0.9693, p = 0.0409) were significantly associated. This association was not significant for PFS (VATI: HR: 0.7084 95% CI: 0.4055–1.2376, p = 0.2259; SATI: HR: 0.6864 95% CI: 0.3932–1.1981, p = 0.1855). SMI and PMI values were not significantly related either PFS (SMI-HR: 0.6728, 95% CI: 0.4031–1.1231, p = 0.1295; PMI-HR: 0.7385, 95% CI: 0.4628–1.1785, p = 0.2036) or OS (SMI-HR: 0.9128, 95% CI: 0.4703–1.7720, p = 0.7876; PMI-HR: 0.6592 95% CI: 0.3684–1.1794, p = 0.1603). No significant association was found between sarcopenia development and PFS (HR: 1.2733 CI: 0.7589–2.1363; p = 0.3602) or OS (HR: 1.1207; CI: 0.5681–2.2107; p = 0.7424). Significant differences between men and women in alcohol intake and nHDI-14 were observed.
Conclusions
Low visceral and subcutaneous adipose tissue index were significantly associated with worse OS in patients with LARC undergoing multimodal treatment. The nHDI-14 was negatively correlated with the duration of observation and patients’ age.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Greater Poland Cancer Centre, Department of Oncology and Immuno-Oncology, Garbary Str. 15, 61-866 Poznan, Poland.
- Poznan University of Medical Sciences, Institute of Oncology, Department of Gynaecological Oncology, Szamarzewskiego Str. 82/84, 60-569 Poznan, Poland.
- Poznan University of Medical Sciences, Electroradiology Department, Garbary Str. 15, 61-866 Poznan, Poland.
- Greater Poland Cancer Centre, Radiology Department, ul. Garbary 15, 61-866 Poznan, Poland.
- Greater Poland Cancer Centre, Greater Poland Cancer Registry, Garbary Str 15, 61-866 Poznan, Poland.
- Poznan University of Medical Sciences, Department of Pathology and Cancer Prevention, Garbary Str. 15, 61-866 Poznan, Poland.
ORCID-Profile: Piotr Radomyski, Maciej Trojanowski, Marta Stelmach-Mardas
Zitieren
APA
Kolenda, P., Mardas, M., Radomyski, P., Trojanowski, M., Litwiniuk, M., Warchoł, W., & Stelmach-Mardas, M. (2025). Body Composition and Survival in Locally Advanced Rectal Cancer Patients Treated with Neoadjuvant Radiochemotherapy. Nutrients, 17(20), 3309. https://doi.org/10.3390/nu17203309
Vancouver
Kolenda P, Mardas M, Radomyski P, Trojanowski M, Litwiniuk M, Warchoł W, et al. Body Composition and Survival in Locally Advanced Rectal Cancer Patients Treated with Neoadjuvant Radiochemotherapy. Nutrients. 2025;17(20):3309. doi:10.3390/nu17203309
BibTeX
@article{Kolenda2025,
author = {Kolenda, Piotr and Mardas, Marcin and Radomyski, Piotr and Trojanowski, Maciej and Litwiniuk, Maria and Warchoł, Wojciech and Stelmach-Mardas, Marta},
title = {Body Composition and Survival in Locally Advanced Rectal Cancer Patients Treated with Neoadjuvant Radiochemotherapy},
journal = {Nutrients},
year = {2025},
volume = {17},
number = {20},
pages = {3309},
doi = {10.3390/nu17203309}
}
EUVIMED